Order Article Reprints

Glueck V, Grimm C, Postl M, Brueffer C, Segui N, Alcaide M, Oton L, Chen Y, Saal LH, Hofstetter G, et al. ctDNA as an Objective Marker for Postoperative Residual Disease in Primary Advanced High-Grade Serous Ovarian Cancer. Cancers. 2025; 17(5):786. https://doi.org/10.3390/cancers17050786

Glueck, Valentina, Christoph Grimm, Magdalena Postl, Christian Brueffer, Nuria Segui, Miguel Alcaide, Lucia Oton, Yilun Chen, Lao H. Saal, Gerda Hofstetter, and et al. 2025. "ctDNA as an Objective Marker for Postoperative Residual Disease in Primary Advanced High-Grade Serous Ovarian Cancer" Cancers 17, no. 5: 786. https://doi.org/10.3390/cancers17050786

Glueck, V., Grimm, C., Postl, M., Brueffer, C., Segui, N., Alcaide, M., Oton, L., Chen, Y., Saal, L. H., Hofstetter, G., Polterauer, S., & Muellauer, L. (2025). ctDNA as an Objective Marker for Postoperative Residual Disease in Primary Advanced High-Grade Serous Ovarian Cancer. Cancers, 17(5), 786. https://doi.org/10.3390/cancers17050786